Effect of the acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study
- 21 January 2004
- Vol. 52 (1) , 20-28
- https://doi.org/10.1002/syn.20002
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Potentiation of amphetamine-induced changes in dopamine and 5-HT by a 5-HT6 receptor antagonistBrain Research Bulletin, 2003
- 5‐HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: Autoradiographic studies with [125I]SB‐258585Synapse, 2002
- The 5-HT6 Receptor Antagonist SB-271046 Selectively Enhances Excitatory Neurotransmission in the Rat Frontal Cortex and HippocampusNeuropsychopharmacology, 2001
- 5-ht6 Receptors as Emerging Targets for Drug DiscoveryAnnual Review of Pharmacology and Toxicology, 2000
- 5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): A Potent, Selective, and Orally Bioavailable 5-HT6 Receptor AntagonistJournal of Medicinal Chemistry, 1999
- Pharmacological actions of the atypical antipsychotic drug clozapine: A reviewSynapse, 1996
- Dopamine-containing neurons in the mammalian central nervous system: Electrophysiology and pharmacologyNeuroscience & Biobehavioral Reviews, 1988
- Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neuronsJournal of Neuroscience, 1983
- Dopamine and the Pathophysiology of Dyskinesias Induced by Antipsychotic DrugsAnnual Review of Neuroscience, 1980
- Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activityLife Sciences, 1978